Press release from Companies: Teckningskursen för teckningsoptioner av serie TO3 i PEPTONIC medical AB har fastställts till 0,05 SEK och nyttjandeperioden inleds den 2 november 2023

Press release from Companies: Peptonics VD Erik Sundquist intervjuas av Finwire.tv

Press release from Companies: Peptonic to present at BioStock Life Science Fall Summit on October 26

Press release from Companies: Peptonic presenterar på BioStock Life Science Fall Summit den 26 oktober

Press release from Companies: Peptonic presenterar på BioStock Life Science Fall Summit den 26 oktober

Reports: PEPTONIC Medical AB (publ), QUARTERLY REPORT Period January – September 2023

Reports: PEPTONIC Medical AB (publ), QUARTERLY REPORT Period January – September 2023

Reports: PEPTONIC Medical AB (publ), Delårsrapport Perioden januari – september 2023

Press release from Companies: Peptonic receives first order from Windsor Pharmaceuticals in Central America

Press release from Companies: Peptonic får första order från Windsor Pharmaceuticals i Centralamerika

Press release from Companies: Peptonic offentliggör preliminär tidplan avseende fusionen med Pharmiva

Press release from Companies: Walmart starts selling Peptonic's products in the US